Table of Content

1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Approach
2.2. Process Of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of The Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions For the Study

3. Executive Summary

4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Market Dynamics
4.2.1.1. Increasing Prevalence of Autoimmune Disorders Driving Growth in Diagnostic Testing
4.2.1.2. Rising Awareness Regarding Autoimmune Diseases Boosting the Adoption of Diagnostic Products
4.2.1.3. Increasing Investments & Funding in The Autoimmune Diseases Space Generating Market Growth Opportunities
4.2.2. Factor Analysis
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Buyers
4.3.2. Bargaining Power of Suppliers
4.3.3. Threat of Substitutes
4.3.4. Threat of New Entrants
4.3.5. Degree of Competition
4.4. Regulatory Analysis
4.4.1. North America
4.4.1.1. U.S.
4.4.1.2. Canada
4.4.2. Europe
4.4.3. Asia-Pacific
4.4.3.1. China
4.4.3.2. India
4.4.3.3. Japan
4.4.4. Latin America
4.4.5. Middle East & Africa

5. Autoimmune Disease Diagnostics Market Assessment? by Product Type
5.1. Overview
5.2. Reagents, Kits, & Assays
5.3. Instruments
5.4. Software & Services

6. Autoimmune Disease Diagnostics Market Assessment?by Test Type
6.1. Overview
6.2. Antinuclear Antibodies (ANA) Test
6.3. C-Reactive Protein Test
6.4. Erythrocyte Sedimentation Rate Test
6.5. Rheumatoid Factor Test
6.6. Immunoglobulins Test
6.7. Routine Blood Test
6.8. Other Autoimmune Tests

7. Global Autoimmune Disease Diagnostics Market?by Disease Type
7.1. Overview
7.2. Systemic Autoimmune Diseases
7.2.1. Rheumatoid Arthritis
7.2.2. Psoriasis
7.2.3. Systemic Lupus Erythematosus
7.2.4. Multiple Sclerosis
7.2.5. Other Systemic Autoimmune Diseases
7.3. Organ-specific Autoimmune Diseases
7.3.1. Type-1 Diabetes
7.3.2. Celiac Disease
7.3.3. Inflammatory Bowel Diseases
7.3.4. Other Organ-specific Autoimmune Diseases

8. Autoimmune Disease Diagnostics Market Assessment?by End User
8.1. Overview
8.2. Diagnostic Laboratories
8.3. Hospitals & Clinics
8.4. Academic & Research Institutes

9. Autoimmune Disease Diagnostics Market Assessment?by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. U.K.
9.3.3. Italy
9.3.4. Spain
9.3.5. France
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. India
9.4.3. Japan
9.4.4. Rest of Asia-Pacific
9.5. Latin America
9.6. Middle East & Africa

10. Competition Analysis
10.1. Overview
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies

11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
11.1 Abbott Laboratories
11.2. F. Hoffmann-La Roche Ltd.
11.3. Siemens Healthineers AG (A Subsidiary of Siemens AG)
11.4. Thermo Fisher Scientific, Inc.
11.5. Bio-Rad Laboratories, Inc.
11.6. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
11.7. Becton, Dickinson and Company
11.8. PerkinElmer, Inc.
11.9. Grifols, S.A.
11.10. Creative Diagnostics
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

12. Appendix
12.1. Available Customization
12.2. Related Reports



List of Figures

Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Autoimmune Disease Diagnostics Market Size, By Product Type, 2023 Vs. 2030 (USD Million)
Figure 8 Global Autoimmune Disease Diagnostics Market Size, By Test Type, 2023 Vs. 2030 (USD Million)
Figure 9 Global Autoimmune Disease Diagnostics Market Size, By Disease Type, 2023 Vs. 2030 (USD Million)
Figure 10 Global Autoimmune Disease Diagnostics Market Size, By End User, 2023 Vs. 2030 (USD Million)
Figure 11 Autoimmune Disease Diagnostics Market Size, By Geography
Figure 12 Impact Analysis of Market Dynamics
Figure 13 National Institutes of Health: Research Funding for Autoimmune Diseases, 2021–2024 (USD Million)
Figure 14 Number of People with Type-1 Diabetes, By Country, 2022
Figure 15 Global Prevalence of Multiple Sclerosis Per 100,000 People, 2013 Vs. 2020
Figure 16 U.S.: Research Funding for Multiple Sclerosis, 2018-2024 (USD Million)
Figure 17 Porter’s Five Forces Analysis
Figure 18 EU Regulatory Pathway - IVDR 2017/746
Figure 19 China: Medical Device Registration Flow Chart (SFDA)
Figure 20 Saudi Arabia: Regulatory Landscape/Marketing Approval Process
Figure 21 Global Autoimmune Disease Diagnostics Market, By Product Type, 2023 Vs. 2030 (USD Million)
Figure 22 Global Autoimmune Disease Diagnostics Market, By Test Type, 2023 Vs. 2030 (USD Million)
Figure 23 U.S.: Number of People with Arthritis (Million) (2020-2035)
Figure 24 Global Ageing Population, By Region (2019 Vs. 2030)
Figure 25 Global Autoimmune Disease Diagnostics Market, By Disease Type, 2023 Vs. 2030 (USD Million)
Figure 26 Multiple Sclerosis Global Prevalence Per 100,000 People (2013 Vs. 2020)
Figure 27 Research Funding for Multiple Sclerosis in The U.S., 2018-2024 (USD Million)
Figure 28 Number of People with Type-1 Diabetes (2022)
Figure 29 Research Funding to NIH For Myasthenia Gravis (2018-2024)
Figure 30 Global Autoimmune Disease Diagnostics Market, By End User, 2023 Vs. 2030 (USD Million)
Figure 31 Global Autoimmune Disease Diagnostics Market, By Region, 2023 Vs. 2030 (USD Million)
Figure 32 North America: Autoimmune Disease Diagnostics Market Snapshot
Figure 33 Europe: Autoimmune Disease Diagnostics Market Snapshot
Figure 34 Germany: Deaths Due to Musculoskeletal and Connective Tissue Diseases, 2015-2020
Figure 35 U.K.: Number of Cases Type 1 Diabetes (0-19 Years), 2019?2022
Figure 36 Italy: Gpd Percentage Spent on Healthcare, 2015?2021
Figure 37 Spain: Number of People Living with HIV (2010-2021)
Figure 38 Asia-Pacific: Autoimmune Disease Diagnostics Market Snapshot
Figure 39 China: Wheat Consumption (1000 Mt) 2015-2022
Figure 40 Japan: Percentage of Population Aged 65 Years and Above (2010-2030)
Figure 41 Australia: Government Research Expenditure on Immunological Diseases 2017 Vs 2020 (USD Million)
Figure 42 Colombia: Lupus Cases 2016-2021
Figure 43 Middle East & North Africa: Healthcare Expenditure (% Of GDP) (2014-2020)
Figure 44 Key Growth Strategies Adopted by Leading Players 2020-2023
Figure 45 Autoimmune Disease Diagnostics Market: Competitive Benchmarking by Test Type
Figure 46 Autoimmune Disease Diagnostics Market: Competitive Benchmarking, By Region
Figure 47 Competitive Dashboard: Autoimmune Disease Diagnostics Market
Figure 48 Abbott Laboratories: Financial Overview (2022)
Figure 49 F. Hoffman-La Roche Ltd: Financial Overview (2021)
Figure 50 Siemens Healthineers AG (A Subsidiary of Siemens AG): Financial Overview (2022)
Figure 51 Thermo Fisher Scientific Inc.: Financial Overview (2022)
Figure 52 Bio-Rad Laboratories: Financial Overview (2022)
Figure 53 Danaher Corporation: Financial Overview (2022)
Figure 54 Becton, Dickinson and Company: Financial Overview (2022)
Figure 55 PerkinElmer, Inc.: Financial Overview (2022)
Figure 56 Grifols, S.A.: Financial Overview (2022)